Genetic and phenotypic diversity in breast tumor metastases

Cancer Research

Volumn 74, Issue 5, 2014, Pages 1338-1348

  Almendro, Vanessa ^a,b,c,j   Kim, Hee Jung ^a,b,c,k   Cheng, Yu Kang ^a,d   Gonen, Mithat ^g   Itzkovitz, Shalev ^e,l   Argani, Pedram ^h   Van Oudenaarden, Alexander ^e,m   Sukumar, Saraswati ⁱ   Michor, Franziska ^a,d   Polyak, Kornelia ^a,b,c,f  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f HARVARD STEM CELL INSTITUTE   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h Departments of Pathology   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j HOSPITAL CLÍNIC   (Spain)

^k MizMedi Hospital   (South Korea)

^l WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^m UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL LEVEL; CELL POPULATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISTANT METASTASIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOLECULAR PATHOLOGY; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; SINGLE CELL ANALYSIS;

BREAST NEOPLASMS; FEMALE; GENETIC VARIATION; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; PHENOTYPE;

EID: 84894584724     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2357-T     Document Type: Article

References (35)

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
2. Fearon ER, Vogelstein B. Agenetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Weng D, Penzner JH, Song B, Koido S, Calderwood SK, Gong J. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res 2012;14:R18.
4. Sanger N, Effenberger KE, Riethdorf S, Van Haasteren V, Gauwerky J, Wiegratz I, et al. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. Int J Cancer 2011;129: 2522-6.
5. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302-12.
6. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-7.
7. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15:559-65.
8. Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, Teixeira MR. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat 2007;102:143-55.
9. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007;11:259-73.
10. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.
11. Norton L, Massague J. Is cancer a disease of self-seeding? Nat Med 2006;12:875-8.
12. Magurran AE. Measuring biological diversity. Malden: Blackwell; 2004.
13. Shannon CE. A mathematical theory of communication. Bell Syst Tech J 1948;27:379-423 and 623-56.
14. Simpson EH. Measurement of diversity. Nature 1949;163:688.
15. Hirschman AO. National power and the structure of foreign trade. Berkeley: University of California; 1945.
16. Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S. American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 2010;6:195-7.
17. Park SY, G̈onen M, Kim HJ, Michor F, Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 2010;120:636-44.
18. Efron B, Tibshirani RJ. An introduction to the bootstrap. London: Chapman & Hall; 1993.
19. Itzkovitz S, Lyubimova A, Blat IC, Maynard M, van Es J, Lees J, et al. Single-molecule transcript counting of stem-cell markers in the mouse intestine. Nat Cell Biol 2012;14:106-14.
20. Singhi AD, Cimino-Mathews A, Jenkins RB, Lan F, Fink SR, Nassar H, et al. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Mod Pathol 2012; 25:378-87.
21. Nikolsky Y, Sviridov E, Yao J, Dosymbekov D, Ustyansky V, Kaznacheev V, et al. Genome-wide functional synergy between amplified and mutated genes in human breast cancer. Cancer Res 2008; 68:9532-40.
22. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-8.
23. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356:217-26.
24. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008;100:672-9.
25. Bloushtain-Qimron N, Yao J, Snyder EL, Shipitsin M, Campbell LL, Mani SA, et al. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 2008;105:14076-81.
26. Bloushtain-Qimron N, Yao J, Shipitsin M, Maruyama R, Polyak K. Epigenetic patterns of embryonic and adult stem cells. Cell Cycle 2009; 8:809-17.
27. Martins FC, De S, Almendro V, Gonen M, Park SY, Blum JL, et al. Evolutionary pathways in BRCA1-Associated breast tumors. Cancer Discov 2012;2:503-11.
28. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 2010;16:876-87.
29. Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K, et al. The CD44+/CD24 phenotype is enriched in basallike breast tumors. Breast Cancer Res 2008;10:R53.
30. Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U, Fink D. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 2003;269:9-12.
31. Merlo LM, Shah NA, Li X, Blount PL, Vaughan TL, Reid BJ, et al. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) 2010;3:1388-97.
32. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009;461:809-13.
33. Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 2010;220:562-73.
34. Lundgren K, Holm K, Nordenskjold B, Borg A, Landberg G. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer. Breast Cancer Res 2008;10:R81.
35. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938-48.